Antiviral Long Acting Drugs Landing in People Living With HIV

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

November 1, 2026

Conditions
HIVAntiviral Agents
Interventions
OTHER

Surveys completion

Completion of surveys: the Feasibility of Implementation Measure (FIM), the Acceptability of Intervention Measure (AIM), the Intervention Appropriateness Measure (IAM), a Likert scale, the EQ-5D-5L questionnaire, the HIV/AIDS-Targeted Quality of Life (HAT-QoL) questionnaire and the HIV Treatment Satisfaction Questionnaire (HIVTSQ).

DRUG

Home administration of CAB+RPV

Drug treatment and follow-up at home (home arm).

DRUG

Hospital administration of CAB+RPV

Drug treatment and follow-up in hospital (hospital arm)

Trial Locations (1)

20127

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

IRCCS San Raffaele

OTHER